AbbVie’s ovarian cancer drug Elahere greenlighted for NHS availability

AbbVie’s ovarian cancer drug Elahere greenlighted for NHS availability  Seeking Alpha

Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.